DFTX

Conviction 100HealthcareScan · Mon, Aug 10, 2026

DFTX$45.15-2.15%

ResistanceSupportVol 14Insider sell

Vol MA14 1.83M

May 11May 28Jun 16Jul 6Jul 23Aug 10

WSB mentions · 24h changelatest -60.00%· 2 mentions

May 11May 28Jun 16Jul 6Jul 23Aug 10

Definium Therapeutics, Inc.MEDICINAL CHEMICALS & BOTANICAL PRODUCTSwww.definiumtx.com ↗

Price45.15

Change-2.15%

Gap-1.01%

Rel volume2.25×

Avg volume1.81M

Avg $ vol79.71M

SMA 2043.92

SMA 5037.91

SMA 200—

Price vs 50+19.11%

Price vs 200—

MA stack—

50/200 cross—

Supertrendup · 38.88

RSI (14)58

MACD hist-0.24

MACD cross—

Stoch %K / %D52 / 71

ADX (14)38

+DI / −DI31 / 12

RSI divergence—

MACD divergence—

ATR %+5.98%

ADR %5.76%

52w high48.45

52w low15.05

From 52w high-6.81%

Above 52w low+200.00%

New 52w highNo

SqueezeOn · 2d

Bollinger width12.78%

%B0.72

Donchian pos51.65%

Donchian high49.70

Donchian low40.29

AVWAP (52w high)45.54

vs AVWAP high-0.87%

AVWAP (52w low)29.12

vs AVWAP low+55.06%

OBV trendFlat

Chaikin MF (20)0.03

Today vs 20d2.25×

Avg vol (14d)1.83M

Avg vol (20d)1.81M

Avg $ vol (20d)79.71M

Market cap6.07B

RS 3m (vs SPY)+93.18%

RS 6m (vs SPY)+169.82%

RS line new highNo

Trend template—

Technical rank85.6

1 week+8.04%

1 month-4.08%

3 months+104.76%

6 months+167.16%

1 year—

YTD+193.56%

P/E-33.01

P/B6.60

P/S—

P/FCF—

EPS-2.06

Div yield—

ROE-20.01%

ROA-16.51%

Debt/Eq0.04

Current6.95

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-69.12%

Price target61.43

Target upside36.06%

Analyst ratingBuy

Institutional64.33%

Ent. value5.45B

Revenue—

Net income-158.99M

Gross profit—

Free cash flow—

IndustryMEDICINAL CHEMICALS & BOTANICAL PRODUCTS

ExchangeNasdaq

Shares out109.07M

Employees106

ListedTue, Mar 3, 2020

Free float90.87M

Float %92.3%

Short interest10.64M

Days to cover4.7d

Short volume45.3%

Squeeze score65 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$1.44 vs −$0.55

Last surprise-161.8% miss

Setup gradeA+

Conviction100 / 100

Pattern quality—

Tech rank85.6 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance48.85

Support31.88

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in DFTX

All disclosures →

No recent disclosed trades by Congress in DFTX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in DFTX · 5 buys · 1 sell

Insider	Side	Shares	Value	Traded	Filed
Barrow Robert Chief Executive Officer · Common Shares · 2026-06-25	Sell	29.21K	$1.3M	2026-06-25	2026-06-26
Barrow Robert Chief Executive Officer · Common Shares · 2026-06-22	Grant	375K	—	2026-06-22	2026-06-22
Karlin Daniel Chief Medical Officer · Common Shares · 2026-06-22	Grant	100K	—	2026-06-22	2026-06-22
Sullivan Mark Chief Legal Officer · Common Shares · 2026-06-22	Grant	62.5K	—	2026-06-22	2026-06-22
Roberts Brandi Chief Financial Officer · Common Shares · 2026-06-22	Grant	62.5K	—	2026-06-22	2026-06-22
Wiley Matthew T. Chief Commercial Officer · Common Shares · 2026-06-22	Grant	62.5K	—	2026-06-22	2026-06-22

SEC filings

EDGAR filings in DFTX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.